UK markets close in 4 hours 8 minutes

Acura Pharmaceuticals, Inc. (ACUR)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0033+0.0001 (+3.13%)
At close: 12:44PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
1,563
1,563
3,570
2,657
Operating expenses
Research development
1,524
1,524
1,781
1,505
Selling general and administrative
1,253
1,253
2,547
1,877
Total operating expenses
2,777
2,777
4,328
3,382
Operating income or loss
-1,214
-1,214
-758
-725
Interest expense
200
200
450
462
Total other income/expenses net
535
535
-
-2,600
Income before tax
-879
-879
-1,208
-3,774
Income tax expense
0
0
0
0
Income from continuing operations
-879
-879
-1,208
-3,774
Net income
-879
-879
-1,208
-3,774
Net income available to common shareholders
-879
-879
-1,208
-3,774
Basic EPS
-0.04
-0.02
-0.04
-0.14
Diluted EPS
-0.04
-0.02
-0.04
-0.14
Basic average shares
32,320
56,801
32,320
26,720
Diluted average shares
32,320
56,801
32,320
26,720